| human | Q5 |
| P244 | Library of Congress authority ID | n2022180255 |
| P496 | ORCID iD | 0000-0002-4041-1352 |
| P214 | VIAF ID | 5672164357929613250009 |
| P735 | given name | Dominique | Q509951 |
| Dominique | Q509951 | ||
| P106 | occupation | researcher | Q1650915 |
| Q36075481 | A prospective, randomized, controlled trial of autologous haematopoietic stem cell transplantation for aggressive multiple sclerosis: a position paper |
| Q92107004 | Allogeneic HSCT for Autoimmune Diseases: A Retrospective Study From the EBMT ADWP, IEWP, and PDWP Working Parties |
| Q39869160 | Allogeneic hematopoietic SCT for patients with autoimmune diseases |
| Q81726271 | Analysis of immune reconstitution after autologous bone marrow transplantation in systemic sclerosis |
| Q99628654 | Association between D-Dimer levels and mortality in patients with coronavirus disease 2019 (COVID-19): a systematic review and pooled analysis |
| Q90288812 | Autoimmune cytopenias (AIC) following allogeneic haematopoietic stem cell transplant for acquired aplastic anaemia: a joint study of the Autoimmune Diseases and Severe Aplastic Anaemia Working Parties (ADWP/SAAWP) of the European Society for Blood a |
| Q44501248 | Autologous HSCT for systemic sclerosis - Authors' reply. |
| Q48626265 | Autologous HSCT in systemic sclerosis: a step forward |
| Q88774424 | Autologous Haematopoietic Stem Cell Transplantation for Crohn's Disease: A Retrospective Survey of Long-term Outcomes From the European Society for Blood and Marrow Transplantation |
| Q38398432 | Autologous Hematopoetic Stem Cell Transplantation for Refractory Crohn Disease: A Randomized Clinical Trial |
| Q58416201 | Autologous bone marrow transplantation in the treatment of refractory systemic sclerosis: early results from a French multicentre phase I-II study |
| Q91134043 | Autologous haematopoietic stem cell transplantation (AHSCT) in autoimmune disease adult patients in France: analysis of the long-term outcome from the French Society for Bone Marrow Transplantation and Cellular Therapy (SFGM-TC) |
| Q92059815 | Autologous haematopoietic stem cell transplantation (HSCT) for anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis: a retrospective survey of patients reported to European Society for Blood and Marrow Transplantation (EBMT) registry |
| Q90317736 | Autologous haematopoietic stem cell transplantation and other cellular therapy in multiple sclerosis and immune-mediated neurological diseases: updated guidelines and recommendations from the EBMT Autoimmune Diseases Working Party (ADWP) and the Joi |
| Q30582614 | Autologous haematopoietic stem cell transplantation for systemic lupus erythematosus: data from the European Group for Blood and Marrow Transplantation registry |
| Q99253732 | Autologous hematopoietic stem cell transplant in systemic sclerosis is associated with marked improvement in health-related quality of life |
| Q63214396 | Autologous hematopoietic stem cell transplantation for autoimmune diseases |
| Q33632260 | Autologous hematopoietic stem cell transplantation for autoimmune diseases: an observational study on 12 years' experience from the European Group for Blood and Marrow Transplantation Working Party on Autoimmune Diseases. |
| Q38893873 | Autologous hematopoietic stem cell transplantation for pediatric multiple sclerosis: a registry-based study of the Autoimmune Diseases Working Party (ADWP) and Pediatric Diseases Working Party (PDWP) of the European Society for Blood and Marrow Tran |
| Q52967863 | Autologous hematopoietic stem cell transplantation in multiple sclerosis: a phase II trial. |
| Q45867293 | Autologous hematopoietic stem cell transplantation in neuromyelitis optica: a registry study of the EBMT Autoimmune Diseases Working Party |
| Q52922473 | Autologous hematopoietic stem cell transplantation reverses skin fibrosis but does not change skin vessel density in patients with systemic sclerosis. |
| Q19862843 | Autologous hematopoietic stem cell transplantation vs intravenous pulse cyclophosphamide in diffuse cutaneous systemic sclerosis: a randomized clinical trial |
| Q93163880 | Autologous hematopoietic stem cell transplantation with reduced-intensity conditioning regimens in refractory Takayasu arteritis: a retrospective multicenter case-series from the Autoimmune Diseases Working Party (ADWP) of the European Society for B |
| Q92710714 | Autologous stem cell transplantation for progressive systemic sclerosis: a prospective non-interventional study from the European Society for Blood and Marrow Transplantation Autoimmune Disease Working Party |
| Q80031296 | Autologous stem cell transplantation for systemic lupus erythematosus |
| Q35554404 | Autologous stem cell transplantation in the treatment of systemic sclerosis: report from the EBMT/EULAR Registry |
| Q36369998 | Autologous stem-cell transplantation in treatment-refractory Crohn's disease: an analysis of pooled data from the ASTIC trial |
| Q85907603 | Cardiac assessment before stem cell transplantation for systemic sclerosis--reply |
| Q50875933 | Cardiac involvement and treatment-related mortality after non-myeloablative haemopoietic stem-cell transplantation with unselected autologous peripheral blood for patients with systemic sclerosis: a retrospective analysis. |
| Q61898137 | Cellules souches mésenchymateuses et immunomodulation : vers de nouvelles stratégies immunosuppressives pour le traitement des maladies auto-immunes ? |
| Q43730907 | Characteristics of joint involvement and relationships with systemic inflammation in systemic sclerosis: results from the EULAR Scleroderma Trial and Research Group (EUSTAR) database. |
| Q40482568 | Clinical determinants of elevated systolic pulmonary artery pressure measured by transthoracic Doppler echocardiography in early systemic sclerosis. |
| Q46740646 | Clinical prediction of 5-year survival in systemic sclerosis: validation of a simple prognostic model in EUSTAR centres |
| Q37582300 | Current state and future directions of autologous hematopoietic stem cell transplantation in systemic lupus erythematosus |
| Q90436722 | Differences associated with age at onset in early systemic sclerosis patients: a report from the EULAR Scleroderma Trials and Research Group (EUSTAR) database |
| Q48515752 | Disability, fatigue, pain and their associates in early diffuse cutaneous systemic sclerosis: the European Scleroderma Observational Study |
| Q46059739 | Do specific antifibrotic properties of immunosuppressive drugs used in the treatment of systemic sclerosis exist? |
| Q40237552 | Does ex vivo CD34+ positive selection influence outcome after autologous hematopoietic stem cell transplantation in systemic sclerosis patients? |
| Q104072363 | Drug-drug interaction (DDI) with direct oral anticoagulant (DOAC) in patients with cancer |
| Q37369608 | EULAR recommendations for the treatment of systemic sclerosis: a report from the EULAR Scleroderma Trials and Research group (EUSTAR). |
| Q93014191 | Editorial: Immune Profile After Autologous Hematopoietic Stem Cell Transplantation for Autoimmune Diseases: Where Do We Stand? |
| Q61163151 | Erratum: Does ex vivo CD34+ positive selection influence outcome after autologous hematopoietic stem cell transplantation in systemic sclerosis patients? |
| Q37310658 | European League Against Rheumatism (EULAR) Scleroderma Trial and Research group (EUSTAR) recommendations for the treatment of systemic sclerosis: methods of elaboration and results of systematic literature research |
| Q91345190 | Evaluating the clinical effectiveness of autologous haematopoietic stem cell transplantation versus disease-modifying therapy in multiple sclerosis using a matching-adjusted indirect comparison: an exploratory study from the Autoimmune Diseases Work |
| Q58814163 | Evolution of serum cytokine profile after hematopoietic stem cell transplantation in systemic sclerosis patients |
| Q89777741 | Evolution, trends, outcomes, and economics of hematopoietic stem cell transplantation in severe autoimmune diseases |
| Q46095995 | From retroperitoneal fibrosis to gastric linitis |
| Q57141769 | Gender differences in early systemic sclerosis patients: a report from the EULAR scleroderma trials and research group (EUSTAR) database |
| Q91297495 | General information for patients and carers considering haematopoietic stem cell transplantation (HSCT) for severe autoimmune diseases (ADs): A position statement from the EBMT Autoimmune Diseases Working Party (ADWP), the EBMT Nurses Group, the EBM |
| Q61282498 | HLA-G a putative susceptibility gene in scleroderma, but only in women |
| Q36020897 | Haematopoietic SCT in severe autoimmune diseases: updated guidelines of the European Group for Blood and Marrow Transplantation |
| Q38868676 | Haematopoietic stem cell transplantation in autoimmune diseases: From basic science to clinical practice |
| Q56956575 | Hematopoietic stem cell therapy for autoimmune diseases - Clinical experience and mechanisms |
| Q52718442 | Homeostatic proliferation leads to telomere attrition and increased PD-1 expression after autologous hematopoietic SCT for systemic sclerosis. |
| Q103039473 | How to screen and diagnose deep venous thrombosis (DVT) in patients hospitalized for or suspected of COVID-19 infection, outside the intensive care units |
| Q104072359 | How to treat venous thromboembolism (TVE) in cancer patients: ten years of multidisciplinary team meetings (MDTM) at Saint-Louis Hospital |
| Q49649475 | Indications and follow-up for autologous hematopoietic stem cell transplantation in autoimmune and autoinflammatory diseases: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC) |
| Q27690791 | Individual quality assessment of autografting by probability estimation for clinical endpoints: a prospective validation study from the European group for blood and marrow transplantation. |
| Q30234696 | International and multidisciplinary expert recommendations for the use of biologics in systemic lupus erythematosus |
| Q36150856 | Kikuchi-Fujimoto disease: retrospective study of 91 cases and review of the literature |
| Q50112982 | Left Ventricle Replacement Fibrosis Detected by CMR Associated With Cardiovascular Events in Systemic Sclerosis Patients |
| Q38939585 | Long-term Outcomes After Autologous Hematopoietic Stem Cell Transplantation for Multiple Sclerosis |
| Q37593784 | Long-term immune reconstitution and T cell repertoire analysis after autologous hematopoietic stem cell transplantation in systemic sclerosis patients. |
| Q33404904 | Long-term outcomes of hematopoietic stem cell transplantation for severe treatment-resistant autoimmune cytopenia in children |
| Q38229870 | Lung and heart-lung transplantation for systemic sclerosis patients. A monocentric experience of 13 patients, review of the literature and position paper of a multidisciplinary Working Group |
| Q91635723 | Lysyl oxidase-a possible role in systemic sclerosis-associated pulmonary hypertension: a multicentre study |
| Q51828286 | Male microchimerism and HLA compatibility in French women with sclerodema: a different profile in limited and diffuse subset. |
| Q89711494 | Management of cancer-related thrombosis in the era of direct oral anticoagulants: A comprehensive review of the 2019 ITAC-CME clinical practice guidelines. On behalf of the Groupe Francophone Thrombose et Cancer (GFTC) |
| Q98188377 | Medication non-adherence after allogeneic hematopoietic cell transplantation in adult and pediatric recipients: a cross sectional study conducted by the SFGM-TC (Francophone Society of Bone Marrow Transplantation and Cellular Therapy) |
| Q37397251 | Mesenchymal stem cells: Stem cell therapy perspectives for type 1 diabetes |
| Q33404870 | New autoimmune diseases after cord blood transplantation: a retrospective study of EUROCORD and the Autoimmune Disease Working Party of the European Group for Blood and Marrow Transplantation |
| Q82565777 | New onset of myasthenia gravis after treatment of systemic sclerosis by autologous hematopoietic stem cell transplantation: sustained autoimmunity or inadequate reset of tolerance? |
| Q46314561 | Onset and outcome of pregnancy after autologous haematopoietic SCT (AHSCT) for autoimmune diseases: a retrospective study of the EBMT autoimmune diseases working party (ADWP). |
| Q47201744 | Patterns and predictors of skin score change in early diffuse systemic sclerosis from the European Scleroderma Observational Study |
| Q44890967 | Peripheral blood regulatory T cells in patients with diffuse systemic sclerosis (SSc) before and after autologous hematopoietic SCT: a pilot study |
| Q39877290 | Prevalence and factors associated with left ventricular dysfunction in the EULAR Scleroderma Trial and Research group (EUSTAR) database of patients with systemic sclerosis |
| Q64983842 | Prognostic Factors for Clinical Response in Systemic Lupus Erythematosus Patients Treated by Allogeneic Mesenchymal Stem Cells. |
| Q58416222 | Prognostic Value of Quantitative Kaposi Sarcoma–Associated Herpesvirus Load in Posttransplantation Kaposi Sarcoma |
| Q98210346 | Pulmonary mucormycosis following autologous hematopoietic stem cell transplantation for rapidly progressive diffuse cutaneous systemic sclerosis: A case report |
| Q61797453 | Recent Advances in the Management of Cancer-Associated Thrombosis: New Hopes but New Challenges |
| Q91812150 | Recent advances in the treatment and prevention of venous thromboembolism in cancer patients: role of the direct oral anticoagulants and their unique challenges |
| Q89367965 | Reproducibility and Utility of the 6-minute Walk Test in Systemic Sclerosis |
| Q38868690 | Resetting the immune response after autologous hematopoietic stem cell transplantation for autoimmune diseases. |
| Q26853573 | SCT for severe autoimmune diseases: consensus guidelines of the European Society for Blood and Marrow Transplantation for immune monitoring and biobanking |
| Q33395411 | Secondary autoimmune diseases occurring after HSCT for an autoimmune disease: a retrospective study of the EBMT Autoimmune Disease Working Party |
| Q37331071 | Stem cell transplantation: a treatment option for severe systemic sclerosis? |
| Q45391416 | Study of anti-Müllerian hormone and its relation to the subsequent probability of pregnancy in 112 patients with systemic lupus erythematosus, exposed or not to cyclophosphamide |
| Q61628531 | The challenge of early systemic sclerosis for the EULAR Scleroderma Trial and Research group (EUSTAR) community. It is time to cut the Gordian knot and develop a prevention or rescue strategy |
| Q56978153 | The three-year incidence of pulmonary arterial hypertension associated with systemic sclerosis in a multicenter nationwide longitudinal study in France |
| Q34369159 | Tolerance and short term efficacy of rituximab in 43 patients with systemic autoimmune diseases |
| Q38966586 | Treatment outcome in early diffuse cutaneous systemic sclerosis: the European Scleroderma Observational Study (ESOS). |
| Q58814283 | Tuberculosis in European cities: establishment of a patient monitoring system over 10 years in Paris, France |
| Q26777402 | Update on mesenchymal stem cell-based therapy in lupus and scleroderma |
| Q53310931 | Validation of French version of the Scleroderma Health Assessment Questionnaire (SSc HAQ). |
| Q74616280 | [A less threatening vertebral lytic lesion] |
| Q81132197 | [All colors on a black skin!] |
| Q51251051 | [Autologous stem cell transplantation for autoimmune diseases: recommendations from the SFGM-TC]. |
| Q77721608 | [Breast plasmacytoma. A new case] |
| Q100692264 | [Crohn's disease and autologous hemapoietic cell transplantation: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)] |
| Q82708590 | [Cytokines in systemic sclerosis] |
| Q83753515 | [Follow-up with the assistance of TB-info software of 208 tuberculosis patients who were treated in 2004] |
| Q74575125 | [Hereditary multiple exostoses after 40 years of development: a case report] |
| Q84272988 | [Introduction to this issue] |
| Q81578631 | [Involvement of TGFbeta1 in fibrotic diseases: role of its effectors, the Smad proteins] |
| Q75310699 | [Quality of life assessment with the MOS-SF36 in patients with systemic sclerosis] |
| Q77479618 | [Re-emergence of tuberculosis and socioeconomic uncertainty] |
| Q84567820 | [Recurrent anemia in a 22-year-old woman] |
| Q80239724 | [Stem cell transplantation in autoimmune diseases] |
| Q81591700 | [Therapeutic intensification and autologous stem cell transplantation in autoimmune diseases] |
| Q54262756 | [Treatment duration of extra-pulmonary tuberculosis: 6 months or more? TB-INFO database analysis]. |
| Q91454243 | [Treatment of cancer associated thrombosis: Which role for direct oral anticoagulants in 2018?] |
| Q82252480 | [Tuberculosis in France: new challenges for practitioners] |
| Q56978299 | Étude de la fonction cardiopulmonaire avant et après traitement par cyclophosphamide dans la sclérodermie systémique sévère : comparaison de deux modes d'administration |
Search more.